Transmission Attenuation Correction (TAC) Package
by Sopha Medical Systems, Inc.
510(k) K952190
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK952190 | Date18 Jan 1996 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KPS
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1200
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Transmission Attenuation Correction (TAC) Package is a system for computed tomography emission tomography, as defined in the device name and specifications. It is designed to correct for transmission attenuation in imaging processes, supporting accurate image reconstruction in nuclear medicine and radiology applications.
The device is supplied by Sopha Medical Systems, Inc., located in Laurel, Maryland. It received FDA 510(k) clearance under K952190 on January 18, 1996, and is classified as a Class II device under regulation number 892.1200. The product code is KPS, and it falls under the radiology medical specialty.
Other devices from Sopha Medical Systems, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the Transmission Attenuation Correction (TAC) Package used for?
The Transmission Attenuation Correction (TAC) Package is designed to correct for transmission attenuation in imaging processes, supporting accurate image reconstruction in nuclear medicine and radiology applications by improving the quality of computed tomography emission tomography scans.
How is the Transmission Attenuation Correction (TAC) Package supplied and by whom?
The Transmission Attenuation Correction (TAC) Package is supplied by Sopha Medical Systems, Inc., located at 14900 Sweitzer Ln., Suite 200, Laurel, Maryland 20707, United States, as a complete system for use in clinical imaging environments.
What regulatory pathway was used for the Transmission Attenuation Correction (TAC) Package and when was it cleared?
The Transmission Attenuation Correction (TAC) Package received FDA 510(k) clearance under K952190 on January 18, 1996, following a traditional submission process, and was found substantially equivalent to a legally marketed predicate device.